Summary & Overview
CPT 86689: Confirmatory Antibody Test for HTLV or HIV
CPT code 86689 represents a laboratory confirmatory antibody test, commonly a Western blot, used to verify reactive screening results for HTLV or HIV. This confirmatory assay is clinically important because it establishes or rules out infection after initial serologic or screening tests, guiding patient management, public health reporting, and infection control measures. Nationally, confirmatory testing remains a critical component of diagnostic pathways for retroviral infections and influences laboratory workflows and payer coverage policies.
Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find benchmarks for utilization and billing practices, a clinical context explaining when 86689 is used in diagnostic algorithms, and summaries of common billing considerations relevant to payers. The content outlines typical sites of service and the nature of the procedure without offering clinical recommendations.
This publication is intended to help billing managers, laboratory directors, and health policy stakeholders understand the role of CPT code 86689, how it fits into confirmatory testing workflows, and what payer coverage patterns and policy implications are commonly associated with confirmatory antibody testing for HTLV and HIV.
Billing Code Overview
CPT code 86689 describes a confirmatory antibody test performed by a laboratory analyst, such as a Western blot, using a patient’s serum to confirm infection with human T-lymphotropic virus (HTLV) or human immunodeficiency virus (HIV). The service typically involves specialized immunoblot techniques that validate results from initial screening assays.
Service type: Laboratory — confirmatory antibody testing
Typical site of service: Clinical laboratory or hospital laboratory
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 34-year-old outpatient presents to a primary care clinic after a reactive HIV screening test on a fourth-generation antigen/antibody assay performed during routine prenatal screening. The clinic draws confirmatory specimens and sends serum to the hospital reference laboratory. The laboratory performs a confirmatory antibody test (e.g., Western blot or other supplemental antibody assay) to verify seropositivity and distinguish false-positive screening results. Results are reported back to the ordering provider for counseling, linkage to care, or further nucleic acid testing if needed. Typical site of service is a hospital or independent clinical laboratory with specimens collected in an ambulatory clinic, community health center, or hospital outpatient phlebotomy area. The encounter commonly includes specimen collection, transport, accessioning, analytic confirmation testing by a laboratory technologist, and final reporting to the ordering clinician.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When only the professional interpretation or report is billed separately from the technical component |
TC | Technical component | When only the technical component (laboratory performance) is billed |
90 | Reference laboratory | When the service is performed by a reference laboratory and billed by the coordinating provider |
91 | Repeat clinical diagnostic laboratory test | For reporting a repeated test on the same day to obtain a reliable result |
59 | Distinct procedural service | If a separate, distinct laboratory procedure is performed on the same day that is not ordinarily bundled |
52 | Reduced services | If testing is partially reduced or not fully performed as described by the CPT code |
53 | Discontinued procedure | If specimen testing was started but discontinued due to patient or specimen issues |
22 | Increased procedural services | For substantially greater lab resources or complexity required to complete the confirmatory assay |
78 | Unplanned return to the lab by the same physician/other qualified health care professional for a related procedure during the postoperative period | Rarely applicable; use when an unplanned return results in additional confirmatory testing after initial procedure |
90 | Reference laboratory | When a reference lab performs the test and another lab or provider bills for coordination (listed intentionally for clarity) |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 261QM0800X | Pathology | Physicians who direct clinical laboratory services and interpret confirmatory serologic testing |
| 261QA0401X | Medical Laboratory | Clinical laboratory scientists/technologists performing the assay (general) |
| 208D00000X | Infectious Disease | Ordering specialists managing diagnostic confirmation and treatment decisions |
| 207Q00000X | Internal Medicine | Primary care physicians ordering initial screening and confirmatory testing |
| 207P00000X | Obstetrics & Gynecology | Providers ordering prenatal HIV/HTLV screening and follow-up testing |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
Z11.4 | Encounter for screening for human immunodeficiency virus [HIV] | Screening encounters that result in reflex confirmatory testing when initial screens are reactive |
R75 | Observed HIV antibody-positive status | Used when antibody tests are positive and confirmation testing is performed |
Z20.6 | Contact with and (suspected) exposure to human immunodeficiency virus [HIV] | Exposure evaluation may prompt confirmatory antibody testing after initial screening |
O98.7 | Viral diseases complicating pregnancy, childbirth and the puerperium; HIV disease in pregnancy | Prenatal positive screens require confirmatory antibody testing for maternal management |
B20 | Human immunodeficiency virus [HIV] disease | Diagnosis established following confirmatory testing and used for ongoing care management |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
86077 | HIV-1/HIV-2 differentiation immunoassay, single or multi-step algorithm, each specimen | Often performed as the next step when initial supplemental antibody testing indicates HIV reactivity to distinguish type |
87389 | Infectious agent antigen detection by immunoassay, multiple-step algorithm, HIV-1 p24 antigen immunoassay (fourth-generation screen) | Commonly used as the initial screening test prior to confirmatory antibody testing |
87534 | Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, quantification | Performed when confirmatory antibody testing is inconclusive or to detect acute infection via RNA testing |
86701 | Antibody; HIV-1 (including HIV-1/2 differentiation when performed) | Alternative or supplemental antibody testing that may be used in the confirmatory algorithm |
99000 | Handling and/or conveyance of specimen | Ancillary code sometimes used by facilities for special specimen handling related to confirmatory testing |